H.C. Wainwright Reiterates Buy Rating, $80 Price Target on Albireo Pharma (ALBO)

July 7, 2022 6:12 AM EDT Send to a Friend
H.C. Wainwright analyst Ed Arce reiterated a Buy rating and $80.00 price target on Albireo Pharma (NASDAQ: ALBO).The analyst comments ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login